Skip to main content
David Wu, MD, Internal Medicine, Columbia, MD

David S Wu MD

Hospice & Palliative Medicine


Palliative physician leader, writer, & educator

Join to view full profile
  • N/AColumbia, MD 21044

Dr. Wu is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • John’s Hopkins University
    John’s Hopkins UniversityMA, Writing , 2023 - 2026
  • University of Washington
    University of WashingtonResidency, Hospice and Palliative Medicine, 2012 - 2013
  • University of Washington
    University of WashingtonResidency, Internal Medicine, 2001 - 2004
  • Baylor College of Medicine
    Baylor College of MedicineClass of 2001

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 2013 - 2027
  • WA State Medical License
    WA State Medical License 2004 - 2013
  • Hospice and Palliative Medicine
    American Board of Internal Medicine Hospice and Palliative Medicine

Awards, Honors, & Recognition

  • Circle of Life Award American Hospital Association, 2023
  • Sojourns Scholar Cambia Health Foundation, 2019

Publications & Presentations

PubMed

Journal Articles

  • A Novel Disease-Causing Synonymous Exonic Mutation in GATA2 Affecting RNA Splicing  
    David Wu, Colin C Pritchard, Blood
  • Mass Cytometry of Hodgkin Lymphoma Reveals a CD4+ Exhausted T-effector and T-regulatory Cell Rich Microenvironment  
    David Wu, Margaret A Shipp, Jonathan R Fromm, Philippe Armand, Blood

Press Mentions

  • AMP Case Report: Unique Patterns of BTK Resistance: Two Independently Arising Resistance Clones in Response to Covalent BTK Inhibitor Therapy in CLL/SLL
    AMP Case Report: Unique Patterns of BTK Resistance: Two Independently Arising Resistance Clones in Response to Covalent BTK Inhibitor Therapy in CLL/SLLOctober 21st, 2025

Committees

  • Chair, Circle of life Award Committee, American Hospital Association 2025 - Present

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: